Ortacta (Rivaroxaban) 20mg is a potent anticoagulant designed to prevent and treat blood clots in patients with conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This extended-release formulation provides sustained inhibition of Factor Xa, a critical component in the blood coagulation cascade, ensuring long-lasting protection against clot formation. Rivaroxaban is particularly beneficial for patients requiring extended anticoagulation therapy, offering a fixed-dose regimen without the need for frequent laboratory monitoring. It is also used to reduce the risk of recurrent DVT and PE after initial treatment.